BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35752212)

  • 41. Dissection of the GTPase mechanism of Ras protein by MD analysis of Ras mutants.
    Friedman ZY; Devary Y
    Proteins; 2005 May; 59(3):528-33. PubMed ID: 15789417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling the role of G12V and G13V Ras mutations in the Ras-GAP-catalyzed hydrolysis reaction of guanosine triphosphate.
    Khrenova MG; Mironov VA; Grigorenko BL; Nemukhin AV
    Biochemistry; 2014 Nov; 53(45):7093-9. PubMed ID: 25339142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The distinct conformational dynamics of K-Ras and H-Ras A59G.
    Lukman S; Grant BJ; Gorfe AA; Grant GH; McCammon JA
    PLoS Comput Biol; 2010 Sep; 6(9):. PubMed ID: 20838576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Haemoglobin inhibits GTP-hydrolysis and GDP/GTP-exchange activities of a low M(r) GTP-binding protein, ras p21.
    Nagata K; Nozawa Y
    Br J Haematol; 1994 Dec; 88(4):706-11. PubMed ID: 7819095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NMR
    Sharma AK; Lee SJ; Zhou M; Rigby AC; Townson SA
    Biomol NMR Assign; 2019 Apr; 13(1):227-231. PubMed ID: 30798456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hybrid QM/MM vs Pure MM Molecular Dynamics for Evaluating Water Distribution within p21
    Tichauer RH; Favre G; Cabantous S; Brut M
    J Phys Chem B; 2019 May; 123(18):3935-3944. PubMed ID: 30991803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KRAS Switch Mutants D33E and A59G Crystallize in the State 1 Conformation.
    Lu J; Bera AK; Gondi S; Westover KD
    Biochemistry; 2018 Jan; 57(3):324-333. PubMed ID: 29235861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GTP hydrolysis mechanisms in ras p21 and in the ras-GAP complex studied by fluorescence measurements on tryptophan mutants.
    Antonny B; Chardin P; Roux M; Chabre M
    Biochemistry; 1991 Aug; 30(34):8287-95. PubMed ID: 1883817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. X-ray crystal structures of transforming p21 ras mutants suggest a transition-state stabilization mechanism for GTP hydrolysis.
    Privé GG; Milburn MV; Tong L; de Vos AM; Yamaizumi Z; Nishimura S; Kim SH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3649-53. PubMed ID: 1565661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural and biochemical characterization of the GTPgammaS-, GDP.Pi-, and GDP-bound forms of a GTPase-deficient Gly42 --> Val mutant of Gialpha1.
    Raw AS; Coleman DE; Gilman AG; Sprang SR
    Biochemistry; 1997 Dec; 36(50):15660-9. PubMed ID: 9398294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delineating the RAS Conformational Landscape.
    Parker MI; Meyer JE; Golemis EA; Dunbrack RL
    Cancer Res; 2022 Jul; 82(13):2485-2498. PubMed ID: 35536216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.
    Liwo A; Gibson KD; Scheraga HA; Brandt-Rauf PW; Monaco R; Pincus MR
    J Protein Chem; 1994 Feb; 13(2):237-51. PubMed ID: 8060496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanistic insights into the effect of phosphorylation on Ras conformational dynamics and its interactions with cell signaling proteins.
    Wang Y; Ji D; Lei C; Chen Y; Qiu Y; Li X; Li M; Ni D; Pu J; Zhang J; Fu Q; Liu Y; Lu S
    Comput Struct Biotechnol J; 2021; 19():1184-1199. PubMed ID: 33680360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.
    Ostrem JM; Peters U; Sos ML; Wells JA; Shokat KM
    Nature; 2013 Nov; 503(7477):548-51. PubMed ID: 24256730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ras-catalyzed hydrolysis of GTP: a new perspective from model studies.
    Maegley KA; Admiraal SJ; Herschlag D
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8160-6. PubMed ID: 8710841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GTP-Bound N-Ras Conformational States and Substates Are Modulated by Membrane and Point Mutation.
    Farcas A; Janosi L
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding.
    Banerjee A; Jang H; Nussinov R; Gaponenko V
    Curr Opin Struct Biol; 2016 Feb; 36():10-7. PubMed ID: 26709496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mapping the nucleotide-dependent conformational change of human N-ras p21 in solution by heteronuclear-edited proton-observed NMR methods.
    Hu JS; Redfield AG
    Biochemistry; 1993 Jul; 32(26):6763-72. PubMed ID: 8329399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conformational states of the switch I region of Ha-ras-p21 in hinge residue mutants studied by fluorescence lifetime and fluorescence anisotropy measurements.
    Kuppens S; Hellings M; Jordens J; Verheyden S; Engelborghs Y
    Protein Sci; 2003 May; 12(5):930-8. PubMed ID: 12717016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C.
    Hunter JC; Gurbani D; Ficarro SB; Carrasco MA; Lim SM; Choi HG; Xie T; Marto JA; Chen Z; Gray NS; Westover KD
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8895-900. PubMed ID: 24889603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.